BIOMAT Database Logo BIOMAT Database Logo

Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation. 1997

M Kawakami, and S Ueda, and T Maeda, and T Karasuno, and H Teshima, and A Hiraoka, and H Nakamura, and K Tanaka, and T Masaoka
Fifth Department of Internal Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, Japan.

We describe a method of diagnosing virus-associated cystitis after allogeneic bone marrow transplantation (BMT) and treatment with vidarabine therapy. At 7-10 days post-BMT when cystitis was suspected, we observed urinary sediments by the Papanicolaou stain to detect virus inclusion bodies. When positive, we examined urinary sediments by transmission electron microscope and measured the diameter of viral particles to determine the families. This process needed only 4 days. Among 16 consecutive cases, adenovirus and polyomavirus were each detected in three. Adenovirus caused hemorrhagic cystitis in two cases and cystitis without macroscopic hematuria in one case. Polyomavirus caused cystitis without macroscopic hematuria in one case. Polyomavirus was also detected in two cases without any symptoms. Vidarabine (10 mg/kg/day i.v.) was administered for 5 days as one course. Soon after one course of vidarabine, most symptoms subsided and virus inclusion bodies disappeared in all cases except for one with severe hemorrhagic cystitis. From these experiences, vidarabine reduces excretion of adenovirus and polyomavirus in the urine of BMT recipients and improves clinical symptoms in some cases of cystitis associated with these viruses.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003556 Cystitis Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain. Cystitides
D005260 Female Females
D006417 Hematuria Presence of blood in the urine. Hematurias
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000257 Adenoviridae Infections Virus diseases caused by the ADENOVIRIDAE. Adenovirus Infections,Infections, Adenoviridae,Infections, Adenovirus,Adenoviridae Infection,Adenovirus Infection,Infection, Adenoviridae,Infection, Adenovirus
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014556 Urine Liquid by-product of excretion produced in the kidneys, temporarily stored in the bladder until discharge through the URETHRA.

Related Publications

M Kawakami, and S Ueda, and T Maeda, and T Karasuno, and H Teshima, and A Hiraoka, and H Nakamura, and K Tanaka, and T Masaoka
Successful vidarabine therapy for adenovirus type 11-associated acute hemorrhagic cystitis after allogeneic bone marrow transplantation.
November 1994, Bone marrow transplantation,
M Kawakami, and S Ueda, and T Maeda, and T Karasuno, and H Teshima, and A Hiraoka, and H Nakamura, and K Tanaka, and T Masaoka
Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation.
February 2000, Bone marrow transplantation,
M Kawakami, and S Ueda, and T Maeda, and T Karasuno, and H Teshima, and A Hiraoka, and H Nakamura, and K Tanaka, and T Masaoka
Clinical effectiveness of hyperbaric oxygen therapy for BK-virus-associated hemorrhagic cystitis after allogeneic bone marrow transplantation.
August 2012, Bone marrow transplantation,
M Kawakami, and S Ueda, and T Maeda, and T Karasuno, and H Teshima, and A Hiraoka, and H Nakamura, and K Tanaka, and T Masaoka
Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation.
March 1991, Bone marrow transplantation,
M Kawakami, and S Ueda, and T Maeda, and T Karasuno, and H Teshima, and A Hiraoka, and H Nakamura, and K Tanaka, and T Masaoka
Hemorrhagic cystitis after allogeneic bone marrow transplantation for thalassemia.
January 1993, Bone marrow transplantation,
M Kawakami, and S Ueda, and T Maeda, and T Karasuno, and H Teshima, and A Hiraoka, and H Nakamura, and K Tanaka, and T Masaoka
Late onset hemorrhagic cystitis after allogeneic bone marrow transplantation.
May 1989, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
M Kawakami, and S Ueda, and T Maeda, and T Karasuno, and H Teshima, and A Hiraoka, and H Nakamura, and K Tanaka, and T Masaoka
Intra-muscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogeneic hemopoietic stem cell transplantation.
December 2000, Bone marrow transplantation,
M Kawakami, and S Ueda, and T Maeda, and T Karasuno, and H Teshima, and A Hiraoka, and H Nakamura, and K Tanaka, and T Masaoka
Mucormycosis Associated With Deferoxamine Therapy After allogeneic Bone Marrow Transplantation.
March 1997, Cancer control : journal of the Moffitt Cancer Center,
M Kawakami, and S Ueda, and T Maeda, and T Karasuno, and H Teshima, and A Hiraoka, and H Nakamura, and K Tanaka, and T Masaoka
[Intravesical cidofovir--instillation therapy for polyomavirus-associated hemorrhagic cystitis after bone marrow transplantation].
May 2007, Der Urologe. Ausg. A,
M Kawakami, and S Ueda, and T Maeda, and T Karasuno, and H Teshima, and A Hiraoka, and H Nakamura, and K Tanaka, and T Masaoka
Hemorrhagic cystitis caused by adenovirus type 34 after allogeneic bone marrow transplantation.
March 2005, Transplantation,
Copied contents to your clipboard!